论文部分内容阅读
多沙唑嗪是一种新型的选择性肾上腺α_1-受体阻滞剂,具有明确的降压和降脂作用。本文对其降脂作用机理进行了讨论。
Doxazosin is a new type of selective adrenal α 1 -receptor blockers, with a clear antihypertensive and lipid-lowering effect. In this paper, the mechanism of its lipid-lowering effect is discussed.